Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 95

Results For "ED"

8104 News Found

Hester Biosciences posts Q1 FY24 consolidated PAT at Rs. 5.86 Cr
News | August 10, 2023

Hester Biosciences posts Q1 FY24 consolidated PAT at Rs. 5.86 Cr

Hester Biosciences has reported total income of Rs. 88.99 crores during the period ended June 30, 2023


Suven Life Sciences posts Q1 FY24 consolidated loss at Rs. 24.09 Cr
News | August 10, 2023

Suven Life Sciences posts Q1 FY24 consolidated loss at Rs. 24.09 Cr

Suven Life Sciences has reported total income of Rs. 9.43 crores during the period ended June 30, 2023


Natural Capsules Q1 FY24 consolidated PAT falls to Rs. 1.82 Cr
News | August 10, 2023

Natural Capsules Q1 FY24 consolidated PAT falls to Rs. 1.82 Cr

Natural Capsules Ltd. has reported total income of Rs. 37.87 crores during the period ended June 30, 2023


IOL Chemicals and Pharmaceuticals posts Q1 FY24 consolidated PAT at Rs. 45.86 Cr
News | August 10, 2023

IOL Chemicals and Pharmaceuticals posts Q1 FY24 consolidated PAT at Rs. 45.86 Cr

IOL Chemicals and Pharmaceuticals has reported total income of Rs. 570.24 crores during the period ended June 30, 2023


Dishman Carbogen Amcis posts Q1 FY24 consolidated PAT at Rs. 17 Cr
News | August 10, 2023

Dishman Carbogen Amcis posts Q1 FY24 consolidated PAT at Rs. 17 Cr

Dishman Carbogen Amcis has reported total income of Rs. 729.91 crores during the period ended June 30, 2023


Lonza launches nebula absorbance reader for streamlined Endotoxin and Pyrogen testing
Digitisation | August 09, 2023

Lonza launches nebula absorbance reader for streamlined Endotoxin and Pyrogen testing

The instrument is fully integrated with Lonza’s latest WinKQCLSoftware to enable data integrity compliance, streamline training, and reduce validation burden


Hikal posts Q1 FY 24 consolidated PAT at Rs. 6.92 Cr
News | August 09, 2023

Hikal posts Q1 FY 24 consolidated PAT at Rs. 6.92 Cr

US FDA approval is in line with de-risking strategy for additional API site to service our global customer base


KIMS posts Q1 FY24 consolidated PAT at Rs. 80.81 Cr
News | August 08, 2023

KIMS posts Q1 FY24 consolidated PAT at Rs. 80.81 Cr

KIMS has reported total income of Rs. 609.14 crores during the period ended June 30, 2023


Torrent Pharmaceuticals posts Q1 FY 24 consolidated PAT at Rs. 378 Cr
News | August 08, 2023

Torrent Pharmaceuticals posts Q1 FY 24 consolidated PAT at Rs. 378 Cr

Torrent Pharmaceuticals has reported total income of Rs. 2625 crores during the period ended June 30, 2023